Zymeworks, Inc. (ZYME)
25.15
-0.81
(-3.12%)
USD |
NASDAQ |
Oct 02, 16:00
25.01
-0.14
(-0.56%)
After-Hours: 20:00
Zymeworks Market Cap : 1.810B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.810B |
| October 01, 2026 | 1.868B |
| September 30, 2026 | 1.906B |
| September 29, 2026 | 1.957B |
| September 28, 2026 | 1.952B |
| September 25, 2026 | 1.908B |
| September 24, 2026 | 1.929B |
| September 23, 2026 | 1.979B |
| September 22, 2026 | 1.984B |
| September 21, 2026 | 1.929B |
| September 18, 2026 | 1.912B |
| September 17, 2026 | 1.978B |
| September 16, 2026 | 1.888B |
| September 15, 2026 | 1.875B |
| September 14, 2026 | 1.932B |
| September 11, 2026 | 1.888B |
| September 10, 2026 | 1.902B |
| September 09, 2026 | 1.954B |
| September 08, 2026 | 2.023B |
| September 04, 2026 | 2.101B |
| September 03, 2026 | 2.152B |
| September 02, 2026 | 2.234B |
| September 01, 2026 | 2.135B |
| August 31, 2026 | 2.116B |
| August 28, 2026 | 2.034B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.088B |
| August 26, 2026 | 2.109B |
| August 25, 2026 | 1.977B |
| August 24, 2026 | 2.070B |
| August 21, 2026 | 2.063B |
| August 20, 2026 | 1.912B |
| August 19, 2026 | 1.958B |
| August 18, 2026 | 1.876B |
| August 17, 2026 | 1.821B |
| August 14, 2026 | 1.808B |
| August 13, 2026 | 1.854B |
| August 12, 2026 | 1.794B |
| August 11, 2026 | 1.750B |
| August 10, 2026 | 1.739B |
| August 07, 2026 | 1.694B |
| August 06, 2026 | 1.664B |
| August 05, 2026 | 1.691B |
| August 04, 2026 | 1.679B |
| August 03, 2026 | 1.606B |
| July 31, 2026 | 1.616B |
| July 30, 2026 | 1.673B |
| July 29, 2026 | 1.621B |
| July 28, 2026 | 1.665B |
| July 27, 2026 | 1.694B |
| July 24, 2026 | 1.684B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 464.42B |
| Aprea Therapeutics, Inc. | 8.612M |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
Market Cap Related Metrics
| PS Ratio | 50.60 |
| PEG Ratio | -0.1183 |
| Price to Book Value | 22.52 |
| Price | 25.15 |
| Earnings Yield | -8.01% |
| PEGY Ratio | -0.1183 |